JPS6410501B2 - - Google Patents

Info

Publication number
JPS6410501B2
JPS6410501B2 JP54024600A JP2460079A JPS6410501B2 JP S6410501 B2 JPS6410501 B2 JP S6410501B2 JP 54024600 A JP54024600 A JP 54024600A JP 2460079 A JP2460079 A JP 2460079A JP S6410501 B2 JPS6410501 B2 JP S6410501B2
Authority
JP
Japan
Prior art keywords
fat emulsion
composition
hemolysis
effect
hemolytic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54024600A
Other languages
English (en)
Japanese (ja)
Other versions
JPS55118419A (en
Inventor
Hiroshi Kodama
Kaoru Ooyama
Ryusaku Shimizu
Masao Nakabayashi
Yoshifumi Nakajima
Takashi Sano
Masaaki Shibata
Kyoshi Goda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Chemical Co Ltd
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Priority to JP2460079A priority Critical patent/JPS55118419A/ja
Priority to GB8006531A priority patent/GB2046092B/en
Priority to US06/125,800 priority patent/US4372949A/en
Priority to DE19803008082 priority patent/DE3008082A1/de
Priority to FR8004736A priority patent/FR2450608A1/fr
Priority to BE0/199647A priority patent/BE882048A/fr
Priority to NL8001292A priority patent/NL8001292A/nl
Priority to SE8001685A priority patent/SE459228B/sv
Priority to CA000346889A priority patent/CA1145260A/en
Priority to IT48066/80A priority patent/IT1145357B/it
Publication of JPS55118419A publication Critical patent/JPS55118419A/ja
Publication of JPS6410501B2 publication Critical patent/JPS6410501B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2460079A 1979-03-05 1979-03-05 Antihemolytic composition consisting of fat emulsion and immunizator and carcinostatic agent containing the same Granted JPS55118419A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP2460079A JPS55118419A (en) 1979-03-05 1979-03-05 Antihemolytic composition consisting of fat emulsion and immunizator and carcinostatic agent containing the same
GB8006531A GB2046092B (en) 1979-03-05 1980-02-27 Pharmaceutical composition containing a lysophospholid and a phospholipid
US06/125,800 US4372949A (en) 1979-03-05 1980-02-29 Treatment of cancer with carcinostatic and immunostimulating agent containing lysophospholipid and phospholipid
DE19803008082 DE3008082A1 (de) 1979-03-05 1980-03-03 Carcinostatisches und die immunreaktion stimulierendes mittel, enthaltend lysophospholipid und phospholipid, und verfahren zur herstellung desselben
FR8004736A FR2450608A1 (fr) 1979-03-05 1980-03-03 Agent carcinostatique et immunostimulant contenant un lysophospholipide et un phospholipide et procede pour le preparer
BE0/199647A BE882048A (fr) 1979-03-05 1980-03-04 Agent carcinostatique et immunostimulant contenant un lysophospholipide et un phospholipide et procede pour le preparer
NL8001292A NL8001292A (nl) 1979-03-05 1980-03-04 Carcinostatisch en immunostimulerend middel.
SE8001685A SE459228B (sv) 1979-03-05 1980-03-04 Anvaendning av en blandning av en lysofosfolipid och en fosfolipid foer framstaellning av en karcinostatisk och immunstimulerande beredning samt foerfarande foer framstaellning av beredningen
CA000346889A CA1145260A (en) 1979-03-05 1980-03-04 Carcinostatic and immunostimulating agent containing lysophospholipid and phospholipid and process for preparing same
IT48066/80A IT1145357B (it) 1979-03-05 1980-03-04 Agente carcinostatico ed immunostimolante contenente lisofosfolipe e fosfolipide e procedimento per prepararlo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2460079A JPS55118419A (en) 1979-03-05 1979-03-05 Antihemolytic composition consisting of fat emulsion and immunizator and carcinostatic agent containing the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP62293142A Division JPS63152327A (ja) 1987-11-20 1987-11-20 脂肪乳剤から成る溶血防止用組成物を含有する製剤

Publications (2)

Publication Number Publication Date
JPS55118419A JPS55118419A (en) 1980-09-11
JPS6410501B2 true JPS6410501B2 (enrdf_load_stackoverflow) 1989-02-22

Family

ID=12142634

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2460079A Granted JPS55118419A (en) 1979-03-05 1979-03-05 Antihemolytic composition consisting of fat emulsion and immunizator and carcinostatic agent containing the same

Country Status (2)

Country Link
JP (1) JPS55118419A (enrdf_load_stackoverflow)
BE (1) BE882048A (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU594066B2 (en) * 1985-07-26 1990-03-01 Yeda Research And Development Co. Ltd. A special lipid mixture for membrane fluidization
US6248553B1 (en) 1998-10-22 2001-06-19 Atairgin Technologies, Inc. Enzyme method for detecting lysophospholipids and phospholipids and for detecting and correlating conditions associated with altered levels of lysophospholipids
US6500633B1 (en) 2000-04-26 2002-12-31 Atairgin Technologies, Inc. Method of detecting carcinomas
CN110636863A (zh) * 2017-05-18 2019-12-31 丘比株式会社 具有自乳化性的组合物及其制造方法及纳米乳液及其制造方法

Also Published As

Publication number Publication date
BE882048A (fr) 1980-09-04
JPS55118419A (en) 1980-09-11

Similar Documents

Publication Publication Date Title
US4271196A (en) Pharmaceutical compositions for parenteral or local administration
KR100504287B1 (ko) 친유성 불활성 가스를 함유하는 약물제제
KR100410937B1 (ko) 프로포폴을 함유하는 혈관주사용 마취제 조성물
KR101951933B1 (ko) 라이소포스파티딜콜린 또는 이의 유도체를 포함하는 지질나노물질 및 이의 제조방법
US4328222A (en) Pharmaceutical compositions for parenteral or local administration
JPH0818989B2 (ja) 脂肪乳剤中のプロスタグランジンの安定化方法
EP0814787A1 (en) Oil in water emulsions containing propofol and edetate
KR101365252B1 (ko) 포스파티딜콜린 함유 주사용 조성물 및 이의 제조방법
JPH0780786B2 (ja) 麻酔用医薬組成物
KR20120087902A (ko) ｐＨ 조절제를 포함하는 탁산의 약학적 용액 및 이의 제조 방법
CN101524329B (zh) 双环醇亚微乳及其制备方法
JPS6410499B2 (enrdf_load_stackoverflow)
GB2103485A (en) Liposomes containing antimony anti-leishmanaisis drugs
JPS6410501B2 (enrdf_load_stackoverflow)
FI85809B (fi) Foerfarande foer framstaellning av genom lyofilisering erhaollbara torrsubstanser.
EP0229844A1 (en) Fat emulsion of prostaglandin i 2?
FI99080C (fi) Menetelmä ruoansulatuskanavan ulkopuoliseen annosteluun tarkoitettujen emulsioiden valmistamiseksi
JPH0145446B2 (enrdf_load_stackoverflow)
NL7900459A (nl) Farmaceutisch preparaat en werkwijze ter bereiding daarvan.
EP0598116B1 (en) Fat emulsion
BÁRÁNY Rate of flow of aqueous humor in normal and scorbutic guinea pigs
EP0145873B1 (en) Transfusion emulsion
JPS59222410A (ja) 薬物保持リポソ−ム製剤
JP2003528134A (ja) 白血球産生の刺激用および腫瘍および原虫症の治療用およびダニ症、節足動物媒介感染の治療用医薬組成物およびその製法
JPS6350330B2 (enrdf_load_stackoverflow)